Literature DB >> 27879458

The Changing Epidemiology of Human T-Cell Lymphotropic Virus Type 1 Infection in Peruvian Female Sex Workers, 1993-2010.

Jenell Stewart1, Kristen Heitzinger2, Simon Pollett3, Martha Calderón4, Jorge Alarcón5, Thanh G N Ton6, Joseph R Zunt7,2,6.   

Abstract

Human T-cell lymphotropic virus type 1 (HTLV-1) was the first human retrovirus to be reported and is associated with neoplastic, neurological, autoimmune, and infectious complications. HTLV-1 is endemic in Peru, with the highest prevalence reported among commercial sex workers. Seroprevalence data collected from Peruvian female sex workers (FSWs) working in Callao over three study periods between 1993 and 2010 were used to examine the secular trend in HTLV-1 prevalence. Between 1993 and 2010, the prevalence of HTLV-1 decreased significantly from 14.5% to 3.1% (P < 0.01). The prevalence of HTLV-1 seropositivity differed significantly by birth cohort (1922-1959, 1960-1969, 1970-1979, and 1980-1992), and for each of the four birth cohorts, the prevalence did not significantly decrease by screening year (P > 0.07). There were no cases of HTLV-1 detected among FSW born after 1979 (N = 224). Participant characteristics associated with HTLV-1 seropositivity were birth in the Andes Mountains region, age, increased time in sex work, younger age of starting sex work, and human immunodeficiency virus (HIV) seropositivity. The secular trend in declining prevalence persisted after adjustment for age, time in sex work, place of birth, and HIV serostatus, with the odds of HTLV-1 infection decreasing approximately 16% per year (adjusted odds ratio = 0.84, 95% confidence interval = 0.78, 0.90). The increasing use of condoms by later birth cohorts noted in our analysis, as well as the increasing availability of free condoms provided by the Peruvian government-which started in the late 1980s before this study-may have been responsible for declining HTLV seroprevalence. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Year:  2016        PMID: 27879458      PMCID: PMC5303039          DOI: 10.4269/ajtmh.16-0014

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  47 in total

Review 1.  Human T-cell lymphotropic virus-I in Latin America.

Authors:  E Gotuzzo; C Arango; A de Queiroz-Campos; R E Istúriz
Journal:  Infect Dis Clin North Am       Date:  2000-03       Impact factor: 5.982

2.  A comparison of the performance of nine commercially available anti-HTLV-I screening assays.

Authors:  A Karopoulos; C Silvester; E M Dax
Journal:  J Virol Methods       Date:  1993-11       Impact factor: 2.014

3.  Sexual practices and prevalence of HIV, HTLV-I/II, and Treponema pallidum among clandestine female sex workers in Lima, Peru.

Authors:  L Trujillo; D Muñoz; E Gotuzzo; A Yi; D M Watts
Journal:  Sex Transm Dis       Date:  1999-02       Impact factor: 2.830

4.  Seroprevalence and risk factors for human T-cell lymphotropic virus (HTLV-I) infection among ethnically and geographically diverse Peruvian women.

Authors:  C Sanchez-Palacios; E Gotuzzo; A-M Vandamme; Y Maldonado
Journal:  Int J Infect Dis       Date:  2003-06       Impact factor: 3.623

5.  Human T cell lymphotropic virus type I infection among female sex workers in Peru.

Authors:  E Gotuzzo; J Sánchez; J Escamilla; C Carrillo; I A Phillips; L Moreyra; W Stamm; R Ashley; E L Roggen; J Kreiss
Journal:  J Infect Dis       Date:  1994-04       Impact factor: 5.226

6.  Decline in human T-cell lymphotropic virus-1 prevalence in urban areas of Bissau, Guinea-Bissau: exploring the association with HIV infections.

Authors:  Zacarias J da Silva; Jens Nielsen; Andreas Andersen; Inés Oliveira; Francisco Dias; Amabélia Rodrigues; Birgitta Holmgren; Sören Andersson; Peter Aaby
Journal:  AIDS       Date:  2009-03-13       Impact factor: 4.177

7.  Prevalences of sexually transmitted infections in young adults and female sex workers in Peru: a national population-based survey.

Authors:  César P Cárcamo; Pablo E Campos; Patricia J García; James P Hughes; Geoff P Garnett; King K Holmes
Journal:  Lancet Infect Dis       Date:  2012-08-08       Impact factor: 25.071

Review 8.  HTLV-1, Immune Response and Autoimmunity.

Authors:  Juarez A S Quaresma; Gilberto T Yoshikawa; Roberta V L Koyama; George A S Dias; Satomi Fujihara; Hellen T Fuzii
Journal:  Viruses       Date:  2015-12-24       Impact factor: 5.048

9.  Prevalence and predictors of cervicitis in female sex workers in Peru: an observational study.

Authors:  Simon Pollett; Martha Calderon; Kristen Heitzinger; Vicky Solari; Silvia M Montano; Joseph Zunt
Journal:  BMC Infect Dis       Date:  2013-04-30       Impact factor: 3.090

10.  Discovery of adult T-cell leukemia.

Authors:  Kiyoshi Takatsuki
Journal:  Retrovirology       Date:  2005-03-02       Impact factor: 4.602

View more
  4 in total

Review 1.  Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection.

Authors:  Nicolas Legrand; Skye McGregor; Rowena Bull; Sahar Bajis; Braulio Mark Valencia; Amrita Ronnachit; Lloyd Einsiedel; Antoine Gessain; John Kaldor; Marianne Martinello
Journal:  Clin Microbiol Rev       Date:  2022-02-23       Impact factor: 50.129

2.  Screening for Human T-Cell Lymphotropic Virus (HTLV) in Pregnant Women in the Peruvian Amazon and Systematic Review with Meta-Analysis of HTLV Infection in Peru.

Authors:  José-Manuel Ramos-Rincón; Sonia Ortiz-Martínez; María-Esteyner Vásquez-Chasnamote; Eva de-Miguel-Balsa; Olga-Nohelia Gamboa-Paredes; Michael-John Talledo-Albujar; Giovanni López-Campana; Juan Carlos Celis-Salinas; Laura Prieto-Pérez; Miguel Górgolas-Hernández; Martin Casapía-Morales
Journal:  Pathogens       Date:  2021-02-25

3.  HTLV-1 Is Also a Sexually Transmitted Infection.

Authors:  Mariana Martel; Eduardo Gotuzzo
Journal:  Front Public Health       Date:  2022-03-31

4.  Work-Related Human T-lymphotropic Virus 1 and 2 (HTLV-1/2) Infection: A Systematic Review.

Authors:  Angela Stufano; Hamid Reza Jahantigh; Francesco Cagnazzo; Francesca Centrone; Daniela Loconsole; Maria Chironna; Piero Lovreglio
Journal:  Viruses       Date:  2021-09-02       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.